← All organizations
Highest phase reached
Phase 2
First clinical trial
Sep 1, 2008Last known activity
Jun 30, 2025
Timeline
1990s
- Jan 1, 1993
V Foundation— Founded
Drugs by trial phase (33 distinct, 21 trials)
Phase 2 (14 own, 0 via acquisition)
Phase 1 (17 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Carcinoma
- Carcinoma, Adenoid Cystic
- Carcinoma, Squamous Cell
- Central Nervous System Neoplasms
- Glioma
- Head and Neck Neoplasms
- Immune System Diseases
- Immunoproliferative Disorders
- Lymphatic Diseases
- Lymphoma
- Lymphoma, B-Cell
- Neoplasms
- Nervous System Neoplasms
- Neuroendocrine Tumors
- Pancreatic Neoplasms
- Peripheral Nervous System Diseases
- Prostatic Neoplasms
- Sarcoma
- Squamous Cell Carcinoma of Head and Neck
Recent trials (21)
- NCT06867822CollaboratorPhase 1/Phase 2Jun 30, 2025
- NCT06691035CollaboratorPhase 1Nov 4, 2024
- NCT06522932CollaboratorPhase 1Oct 30, 2024
- NCT06578637CollaboratorN/ASep 20, 2024
- NCT05660408CollaboratorPhase 1/Phase 2Apr 30, 2023
- NCT05478837CollaboratorPhase 1Feb 1, 2023
- NCT04112641CollaboratorPhase 2Dec 1, 2019
- NCT04052334CollaboratorPhase 1Aug 8, 2019
- NCT03999684CollaboratorPhase 2Jul 31, 2019
- NCT03795610CollaboratorPhase 2Jun 30, 2019
- NCT03696784CollaboratorPhase 1Mar 12, 2019
- NCT03733119CollaboratorPhase 2Nov 13, 2018
- NCT03192462CollaboratorPhase 1/Phase 2Jan 18, 2018
- NCT03086616CollaboratorPhase 1Jun 1, 2017
- NCT02963051CollaboratorPhase 1Feb 1, 2017
Details
- Founded
- Cary, NC, US Jan 1, 1993
- Last known activity
- Jun 30, 2025